Design Therapeutics, Inc. (DSGN) Operating income 2020–2025
Design Therapeutics, Inc. (DSGN) annual operating income history from SEC filings — each fiscal year as reported.
-$79.5MFY2025 · since FY2020: -$8.3M → -$79.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.5M | -27.4% |
| FY2024 | -$62.4M | +20.2% |
| FY2023 | -$78.2M | -15.7% |
| FY2022 | -$67.6M | -88.6% |
| FY2021 | -$35.8M | -330.1% |
| FY2020 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DSGN financial trends
DSGN RevenueDSGN Net incomeDSGN Net marginDSGN Gross profitDSGN Gross marginDSGN Operating marginDSGN Operating cash flowDSGN Free cash flowDSGN Capital expendituresDSGN Return on equityDSGN Stock buybacksDSGN Dividends paidDSGN Total assetsDSGN Total liabilitiesDSGN Shareholders’ equityDSGN overview →